Non-linear Optical Collagen Cross-linking (NLO CXL) for Treatment of Keratoconus

非线性光学胶原交联 (NLO CXL) 治疗圆锥角膜

基本信息

  • 批准号:
    10391522
  • 负责人:
  • 金额:
    $ 38.07万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-08-01 至 2025-04-30
  • 项目状态:
    未结题

项目摘要

Project Summary/Abstract Collagen crosslinking (CXL) using single photon, 380 nm, UVA light to photoactivate riboflavin (Rf) is known to induce a two-fold increase in collagen stiffness and 1-3 diopters of corneal flattening. While these effects have been shown to have significant therapeutic benefits for both treating Keratoconus and correcting minor refractive errors, there are several major drawbacks to this procedure, including post-operative pain and and delayed visual recovery with increased risk of bacterial infection and corneal scaring. In our recently completed, NEI funded research project we developed a two-photon, nonlinear optical (NLO) CXL approach using infrared femtosecond laser (FS) light that limits Rf photoactivation to the two-photon focal volume of an objective lens. This device uses an amplified FS laser to generate 760 nm, 0.3 μJ pulses at less than 46.1 mW total power (under the ANSI thermal limit for laser eye exposure), and can crosslink a 4 mm diameter area in less than 4 min, significantly enhance stromal stiffness 1.6 fold, and induce 1 to 2 diopters of corneal flattening in live rabbits. As part of this project, we have also developed a novel, FS laser based, corneal epithelial micromachining approach to create Microchannels (MicroCh) through the epithelium to greatly enhance transepithelial (TE) Rf diffusion. Goal of this project is to test the hypothesis that post-operative pain and delayed visual recovery is due to the excessive cellular damage caused by UVA CXL and that TE-NLO CXL shows significantly less cell damage with faster visual recovery. This hypothesis will be tested through the following specific aims: Aim 1. Optimize MicroCh TE Rf stromal penetration by determining the effects of pulse energy, density and depth on Rf stromal concentration and epithelial/stromal integrity as compared to other excipient TE approaches using ex vivo rabbit eyes. Aim 2. Determine the effects of TE Rf penetration on corneal epithelial and stromal integrity comparing MicroCh to optimal excipient Rf approaches identified in SA1 using an ex vivo rabbit eye model to measure epithelial/stromal cell death and induced inflammatory gene expression at 3 hours and 24 hours with and without UVA or NLO CXL. Aim 3. Determine the effects MicroCh Rf delivery and UVA versus NLO CXL in live rabbits by assessing the effects on epithelial integrity, corneal sensitivity, stromal inflammation, wound healing and visual recovery.
项目摘要/摘要 胶原蛋白交联(CXL)利用单光子,380 nm,UVA光激活核黄素(RF)是 已知会导致胶原蛋白硬度增加两倍,角膜变平的屈光度为1-3。而这些 结果表明,治疗圆锥角膜和矫正圆锥角膜都有显著的疗效。 轻微的屈光不正,这种手术有几个主要的缺点,包括术后疼痛和 视力恢复延迟,细菌感染和角膜创伤的风险增加。在我们最近 完成了NEI资助的研究项目,我们开发了一种双光子、非线性光学(NLO)CXL方法 使用红外飞秒激光(FS)光,将RF光激活限制为双光子焦点体积 物镜。该装置使用放大的FS激光产生760 nm、0.3μJ的脉冲,脉冲频率小于46.1. MW总功率(低于ANSI激光眼睛曝光的热极限),并可交叉连接直径4 mm的区域 在不到4分钟的时间内,基质硬度显著增加1.6倍,并诱导角膜屈光度1~2度 在活的兔子身上压平。作为这个项目的一部分,我们还开发了一种基于FS激光的新型角膜 上皮微机械加工方法通过上皮创造微通道(Microch)来极大地 增强跨上皮(TE)射频扩散。这个项目的目标是检验这样一种假设,即术后疼痛 视力恢复延迟是由于UVA CXL和TE-NLO造成的细胞过度损伤 CXL显示出更小的细胞损伤和更快的视觉恢复。这一假设将通过 以下具体目标:目标1.通过确定以下影响来优化微通道射频基质穿透 脉冲能量、密度和深度对射频间质浓度和上皮/间质完整性的影响 其他赋形剂TE方法使用体外兔眼。目的2.确定TE射频穿透的效果 比较MicroCH和最佳赋形剂RF方法对角膜上皮和基质完整性的影响 SA1利用体外兔眼模型测量上皮/基质细胞死亡和诱导的炎症基因 在有无UVA或NLO CXL的情况下,在3小时和24小时表达。目的3.测定微循环的影响 射频给药和UVA与NLO CXL对活体兔角膜上皮完整性、角膜的影响 敏感性、间质炎症、伤口愈合和视力恢复。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

James V Jester其他文献

James V Jester的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('James V Jester', 18)}}的其他基金

Core 1. Ocular Microanatomy Core (OMC)
核心 1. 眼部显微解剖核心 (OMC)
  • 批准号:
    10676930
  • 财政年份:
    2022
  • 资助金额:
    $ 38.07万
  • 项目类别:
Non-linear Optical Collagen Cross-linking (NLO CXL) for Treatment of Keratoconus
非线性光学胶原交联 (NLO CXL) 治疗圆锥角膜
  • 批准号:
    10222916
  • 财政年份:
    2014
  • 资助金额:
    $ 38.07万
  • 项目类别:
Non-linear Optical Collagen Cross-linking (NLO CXL) for Treatment of Keratoconus.
用于治疗圆锥角膜的非线性光学胶原交联 (NLO CXL)。
  • 批准号:
    8752184
  • 财政年份:
    2014
  • 资助金额:
    $ 38.07万
  • 项目类别:
Non-linear Optical Collagen Cross-linking (NLO CXL) for Treatment of Keratoconus
非线性光学胶原交联 (NLO CXL) 治疗圆锥角膜
  • 批准号:
    10611375
  • 财政年份:
    2014
  • 资助金额:
    $ 38.07万
  • 项目类别:
Non-linear Optical Collagen Cross-linking (NLO CXL) for Treatment of Keratoconus.
用于治疗圆锥角膜的非线性光学胶原交联 (NLO CXL)。
  • 批准号:
    9303387
  • 财政年份:
    2014
  • 资助金额:
    $ 38.07万
  • 项目类别:
Age-Related Meibomian Gland Dysfunction
年龄相关的睑板腺功能障碍
  • 批准号:
    8714514
  • 财政年份:
    2011
  • 资助金额:
    $ 38.07万
  • 项目类别:
Age-Related Meibomian Gland Dysfunction
年龄相关的睑板腺功能障碍
  • 批准号:
    8527787
  • 财政年份:
    2011
  • 资助金额:
    $ 38.07万
  • 项目类别:
Age-Related Meibomian Gland Dysfunction
年龄相关的睑板腺功能障碍
  • 批准号:
    8710230
  • 财政年份:
    2011
  • 资助金额:
    $ 38.07万
  • 项目类别:
Age-Related Meibomian Gland Dysfunction
年龄相关的睑板腺功能障碍
  • 批准号:
    8085875
  • 财政年份:
    2011
  • 资助金额:
    $ 38.07万
  • 项目类别:
Age-Related Meibomian Gland Dysfunction
年龄相关的睑板腺功能障碍
  • 批准号:
    8334615
  • 财政年份:
    2011
  • 资助金额:
    $ 38.07万
  • 项目类别:

相似海外基金

New roles of IFN-inducible OAS proteins in innate immune defense against bacterial infections
IFN诱导的OAS蛋白在针对细菌感染的先天免疫防御中的新作用
  • 批准号:
    10649771
  • 财政年份:
    2023
  • 资助金额:
    $ 38.07万
  • 项目类别:
Derivation and validation of a clinical prediction rule to identify febrile infants 61 to 90 days old at low and non-negligible risk of invasive bacterial infections
推导和验证临床预测规则,以识别 61 至 90 天大的发热婴儿,其侵袭性细菌感染的风险较低且不可忽略
  • 批准号:
    10574286
  • 财政年份:
    2023
  • 资助金额:
    $ 38.07万
  • 项目类别:
Structural and functional studies of YbtPQ for fighting bacterial infections
YbtPQ 对抗细菌感染的结构和功能研究
  • 批准号:
    10644889
  • 财政年份:
    2023
  • 资助金额:
    $ 38.07万
  • 项目类别:
A gut feeling: How can gastrointestinal bacterial infections alter female reproductive tract immunity and control of sexually transmitted infections
直觉:胃肠道细菌感染如何改变女性生殖道免疫力和性传播感染的控制
  • 批准号:
    MR/X031993/1
  • 财政年份:
    2023
  • 资助金额:
    $ 38.07万
  • 项目类别:
    Research Grant
Molecular probes to diagnose pathoadapatations in bacterial infections
诊断细菌感染病理适应的分子探针
  • 批准号:
    EP/X014479/1
  • 财政年份:
    2023
  • 资助金额:
    $ 38.07万
  • 项目类别:
    Research Grant
Using Small Area Variation Analysis to Investigate Sources of Practice Variation for Febrile Infants at Risk for Invasive Bacterial Infections
使用小面积变异分析来调查有侵袭性细菌感染风险的发热婴儿的实践变异来源
  • 批准号:
    10588846
  • 财政年份:
    2023
  • 资助金额:
    $ 38.07万
  • 项目类别:
Host Directed Orynotide for MDR Gram Negative Bacterial Infections
宿主定向 Orynotide 用于治疗耐多药革兰氏阴性细菌感染
  • 批准号:
    10674221
  • 财政年份:
    2023
  • 资助金额:
    $ 38.07万
  • 项目类别:
SimCell vaccines against Staphylococcus aureus bacterial infections
针对金黄色葡萄球菌细菌感染的 SimCell 疫苗
  • 批准号:
    10073241
  • 财政年份:
    2023
  • 资助金额:
    $ 38.07万
  • 项目类别:
    Grant for R&D
I-Corps: Mitigating Multidrug Resistant Bacterial Infections with Biocompatible and Environmentally Benign Nanoantibiotics
I-Corps:利用生物相容性且对环境无害的纳米抗生素减轻多重耐药细菌感染
  • 批准号:
    2306943
  • 财政年份:
    2023
  • 资助金额:
    $ 38.07万
  • 项目类别:
    Standard Grant
Multidimensional development of high-affinity anti-glycan antibodies to fight deadly bacterial infections
多维开发高亲和力抗聚糖抗体以对抗致命细菌感染
  • 批准号:
    10549640
  • 财政年份:
    2023
  • 资助金额:
    $ 38.07万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了